P-gp is overexpressed in epilepsy [42] and amyotrophic lateral sclerosis [43], and downregulated in Parkinson’s and Alzheimer’s diseases, where it leads to impaired β-amyloid clearance [16]. Here, PGP is linked to Alzheimer disease.